newsfilter
← Latest News
PR Newswire·

The NYSE Welcomes vVARDIS as a Publicly Listed Company

  • vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi & Dr. Goly Abivardi have launched the company on the NYSE.
  • The Swiss dental technology firm focuses on treating early tooth decay with a drill-free, needle-free approach.
  • Flagship product Curodont® Repair Fluoride Plus utilizes proprietary peptide technology to support natural enamel remineralization.
  • Tooth decay affects 2.5 billion people globally & nearly 90% of U.S. adults have experienced decay.
  • Dental anxiety impacts nearly 73% of U.S. adults, with 21% avoiding the dentist due to fear.
  • The founders spent 25 years developing the treatment, which has already treated over 2.5 million teeth.
  • Curodent® is currently available in more than 20% of U.S. dental practices.
Company
New York Stock Exchange
Keywords
New York Stock Exchange